Events

In an era where generative artificial intelligence is becoming ubiquitous, understanding the IP and commercialization landscape around it becomes crucial for researchers and startup founders. The Center for Technology Licensing at Cornell University knows the importance of securing strong IP for successful commercialization and developing the creation of technologies with a positive global impact in mind while ensuring safe and trustworthy practices.

This virtual event focuses on IP rights within AI-related technologies. Join us for an in-depth exploration with Jason Novak, Partner at Norton Rose Fulbright, specializing in Precision Medicine and Digital Health, alongside Douglas Link, a Member at Cozen O'Connor. They will provide invaluable insights into achieving robust IP protection and navigating the patent landscape in the digital health and AI sectors.

Register here. 

Led by the NSF I-Corps Hub: Interior Northeast (IN I-Corps), these free, month-long NSF I-Corps Regional Courses are designed for university-based STEM researchers and early-stage founders interested in evaluating the market potential of their technology and learning valuable entrepreneurial skills.

The following virtual course is open to tech researchers in all STEM fields:  

• April 1 – May 1: Hosted by IN I-Corps partner University of Pittsburgh. Apply by March 6. 

Applications will be reviewed on a rolling basis. Apply now! Questions? Contact icorps@cornell.edu or visit www.in-icorps.org/regional-courses. 

Ready to secure non-dilutive funding to take your startup to the next level?

Join Kirk Macolini, President of InteliSpark, LLC, for this virtual workshop providing insights into the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) application process and how to find other non-dilutive funding sources. During the workshop, Macolini will discuss and answer questions regarding:

• Writing and submitting a successful SBIR/STTR proposal
• Locating additional non-dilutive funding sources
• Applying to the SBIR/STTR Assistance Program, which can help eligible companies, based in New York state, hire a qualified grant writing consultant to help them develop a proposal
• Upon registering, participants will receive access to the SBIR/STTR video series, a set of short videos containing valuable background information, which they are encouraged to view prior to the workshop. The pre-workshop video series covers:
• An overview of the SBIR/STTR programs
• Program eligibility requirements
• Differences between SBIR and STTR agencies
• Using SBIR/STTR to enhance your company’s value

Register here to reserve your spot. 

The Center for Innovative NeuroTech Advancement (CINTA) & NeuroTech Harbor (NTH) announce the Cycle 4 Award Competition supported by the NIH Blueprint MedTech Program. This program is seeking collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system.

CINTA and NTH are calling for proposals leading to commercialization of groundbreaking preventative, therapeutic, and/or diagnostic medical devices. At a minimum, projects should have already clearly demonstrated proof-of-concept. The technologies proposed must have a pathway to a prototype ready for first-in-human testing within 4 years and have a viable pathway to commercial development.

Applications must focus on an intended use involving the nervous system or addressing consequences of such a disease or injury in an area of interest of the Participating Institutes/Centers.

Two kinds of awards may be issued for applications submitted to this solicitation:

• Optimizer awards will rarely exceed $500,000 in direct costs per year for a period of up to 4 years. In addition to monetary support, awardees will receive mentoring and resources and support services necessary for translation will be available.
• Seedling awards provide support for six months, a $25,000 stipend, and $25,000 to hire subject matter experts. Mentors will work with awardees throughout the project to help resolve specifically identified gap on the path to commercialization.

Applicants must submit pre-proposals through the Blueprint MedTech: Incubator Hubs Program online application system no later than 11:59 pm ET on February 29, 2024. Pre-proposals are submitted through a simple online application form equivalent to approximately three pages.

Eligible applicants will be invited to submit full proposals through the same online application system. The full proposal form is equivalent to approximately ten pages and will undergo review by CINTA and NTH.

To learn more about the award and apply, visit their website here. Weekly informational webinars and office hours by appointment are available in February 2024. 

You're invited to join this anchor program for attracting attention to Weill Cornell Medicine's life science innovations. The full-day program features an interview with Bruce C. Ratner, WCM Board of Fellows member, an opportunity to celebrate innovation and entrepreneurship at WCM, and engagement with like-minded founders, investors and industry representatives. Read the full agenda and register here. 

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. 

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. Successful applicants will receive funding of up to $400,000 over 2 years. Check out the attached PDF for focus areas.

Interested researchers are invited to:

• Attend information webinars to learn more about the initiative: Webinars will be held on:

Wednesday, 1/17/24 4pm ET
Monday, 2/5/24 12pm ET

• Contact Deanna Scarcella at des4016@med.cornell.edu to obtain webinar links and online application submission instructions
• Send Deanna Scarcella (des4016@med.cornell.edu) a NON-CONFIDENTIAL (make sure to EXCLUDE any unpublished data or information) abstract by Tues, Feb 20, 2024 which will be reviewed by the Center for Technology Licensing (CTL).  Please note: CTL will upload it to the CSL online portal by Tues, Feb 27.

Calling pre-seed and seed innovators and entrepreneurs in Oncology, Cell & Gene Therapy, Cardiovascular, Immunology, Radiology, and Digital Health!

Do you have disruptive science but struggle to bring it to life in the entrepreneurial world? Bayer's passion is to enable and support standout healthcare innovation.

Take your innovation to new heights and join Bayer's Expert Mondays 2024, a series of knowledge exchange sessions to supercharge your startup’s growth.

Each one-hour Bayer's Expert Monday includes a live Q&A with respective Bayer Experts. You can stay for a Meet & Greet with Bayer Scouts and Scientific Finders. Please reserve 30 additional minutes in your schedule for the Meet & Greet after the Bayer Expert session.

These sessions are not intended for service providers, consultants, IT providers, etc. They are designed for drug developers and healthcare researchers seeking collaboration with big pharma and out-licensing opportunities later in their journey. Session recordings are NOT distributed afterward. Live attendance is necessary to get the most out of the expert sessions and network with the Bayer Pharma team.

The Feb. 26 event features Dr. Bernhard Glombitza, VP, Head of Clinical OPS EMEA & APAC. Reserve your spot here. 

Are you an entrepreneur ready to take your product idea to the next level? Rev: Ithaca Startup Works invites you to take a deep dive into prototyping this summer!

Over 10 weeks, Rev’s Prototyping Hardware Accelerator guides product teams to determine if their ideas are commercially desirable, technologically feasible, and economically viable. Upon completion of the program, participants are positioned to recruit team members, bring on partners, initiate work with contract manufacturers and pitch to investors. Teams will receive a stipend of up to $2,000 to advance their prototype.

The program offers a MedTech Track in partnership with Cornell Biomedical Engineering and Weill Cornell. The MedTech track provides access to specialized prototyping equipment, regulatory resources and research and medical professionals in the field.  

The accelerator is held in person at Rev: Ithaca Startup Works in Ithaca, New York beginning in late May 2024. The program is free and open to the public. Applications are now open. Early admission deadline February 16, 2024. Applications close March 25, 2024. Learn more and apply here. Questions about the program can be directed to rev@revithaca.com.   

In this Center for Technology Licensing New Ventures Series webinar, Kirsten Leute at Osage University Partners (OUP) will focus on how an entrepreneur or a faculty-entrepreneur can develop and deliver a pitch to gain interest and commitment from potential investors.

Pitching an early-stage science- and technology-based startup to potential funders can be intimidating. Learning how to tailor your presentation and understanding what motivates funders to say yes, or at least not give you an outright no, are important aspects of preparing for your initial pitch. This talk will be structured around OUP’s many years of experience in hearing pitches and reviewing pitch decks to provide insight on creating and presenting an initial startup pitch to funders. Register here. 

The BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites you to tune into our virtual interview with Dr. Carlo Yuvienco, Director of the Ford Center Incubator at The Rockefeller University. The discussion will focus on how the Ford Center Incubator aims to support life science startups from the Upper East Side ecosystem as well as its distinct laboratory amenities and service offerings. A prerecorded walk-through of the wet lab space and private offices will be shown. Register here.